(Q51229819)

1 April 2018

title

Multiplex analysis of circulating cytokines in the sera of patients with different clinical forms of visceral leishmaniasis. (English)

1 reference

1 April 2018

main subject

patient

0 references

visceral leishmaniasis

1 reference

Caryn Bern

5

0 references

Rashidul Haque

4

object named as

Rashidul Haque

1 reference

1 April 2018

Katie M Kurkjian

1

1 reference

1 April 2018

Aida J Mahmutovic

2

1 reference

1 April 2018

Kathryn L Kellar

3

1 reference

1 April 2018

W Evan Secor

6

1 reference

1 April 2018

publication date

1 May 2006

1 reference

1 April 2018

published in

Cytometry Part A

1 reference

1 April 2018

volume

69

1 reference

1 April 2018

issue

5

1 reference

1 April 2018

page(s)

353-358

1 reference

1 April 2018

Clinical spectrum of Leishmaniasis

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20256

Risk factors for kala-azar in Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20256

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20256

7 January 2021

Leishmaniasis: current situation and new perspectives

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20256

7 January 2021

Visceral leishmaniasis in immunocompromised patients with and without AIDS: a comparison of clinical features and prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20256

7 January 2021

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20256

7 January 2021

Inhibition of host cell signal transduction by Leishmania: observations relevant to the selective impairment of IL-12 responses

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20256

7 January 2021

The regulation of immunity to Leishmania major

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20256

7 January 2021

Profile of human T cell response to leishmanial antigens. Analysis by immunoblotting

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20256

7 January 2021

Cellular profile of cytokine production in a patient with visceral leishmaniasis: gammadelta+ T cells express both type 1 cytokines and interleukin-10.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20256

7 January 2021

Splenic cytokine responses in Indian kala-azar before and after treatment

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20256

7 January 2021

Post-kala-azar dermal leishmaniasis.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20256

7 January 2021

A cloned antigen (recombinant K39) of Leishmania chagasi diagnostic for visceral leishmaniasis in human immunodeficiency virus type 1 patients and a prognostic indicator for monitoring patients undergoing drug therapy

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20256

7 January 2021

Application of an improved method for the recombinant k 39 enzyme-linked immunosorbent assay to detect visceral leishmaniasis disease and infection in Bangladesh

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20256

7 January 2021

Multiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatants

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20256

7 January 2021

Multiplexed microsphere-based flow cytometric immunoassays for human cytokines.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20256

7 January 2021

Potential role for interleukin-10 in the immunosuppression associated with kala azar

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20256

7 January 2021

In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20256

7 January 2021

IL-10 mediates susceptibility to Leishmania donovani infection.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20256

7 January 2021

IL-12 as an adjuvant for cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20256

7 January 2021

Immunopathology of post kala-azar dermal leishmaniasis (PKDL): T-cell phenotypes and cytokine profile

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20256

7 January 2021

Identifiers

DOI

10.1002/CYTO.A.20256

1 reference

1 April 2018

release_is3vt7of7bcr5lns52e73mcsya

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/is3vt7of7bcr5lns52e73mcsya

24 November 2022

mapped directly with Wikidata item

1 reference

1 April 2018